EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects

Dr. Sachin T Jose

Journal of Advanced Multidisciplinary Studies (JAMS) · 30.10.2026

DOI: 10.68050/jams.2026.893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Advanced Multidisciplinary Studies (JAMS), online erschienen am 30.10.2026. Verfasst von Dr. Sachin T Jose. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapamycin (sirolimus), originally isolated from Streptomyces hygroscopicus, is a macrolide compound that has profoundly influenced modern biomedical research through its inhibition of the mechanistic target of rapamycin (mTOR) pathway.

Objective

This review aims to synthesize current knowledge on the microbiological origin, molecular mechanisms, therapeutic applications, and biotechnological optimization of rapamycin, with emphasis on recent advances and emerging challenges.

Methods

A comprehensive literature analysis was conducted using peer-reviewed articles focusing on rapamycin biosynthesis, mTOR signaling, clinical applications, and production strategies.

Results

Rapamycin and its analogs (rapalogs) demonstrate significant clinical value in transplantation, oncology, neurodegenerative diseases, and aging research. Advances in metabolic engineering, synthetic biology, and nanodelivery systems have substantially improved production yields and pharmacological performance. However, limitations related to solubility, bioavailability, metabolic side effects, and long-term safety remain.

Conclusion

Rapamycin remains a cornerstone molecule linking microbial natural products to translational medicine. Continued optimization of its production and selective modulation of mTOR signaling are critical for expanding its future therapeutic potential.

Zitieren

APA

Jose, D. S. T. (2026). Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects. Journal of Advanced Multidisciplinary Studies (JAMS). https://doi.org/10.68050/jams.2026.893

Vancouver

Jose DST. Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects. Journal of Advanced Multidisciplinary Studies (JAMS). 2026. doi:10.68050/jams.2026.893

BibTeX
@article{Jose2026,
  author = {Jose, Dr. Sachin T},
  title = {Rapamycin: From Microbial Discovery to Therapeutic Innovations — Advances, Challenges, and Future Prospects},
  journal = {Journal of Advanced Multidisciplinary Studies (JAMS)},
  year = {2026},
  doi = {10.68050/jams.2026.893}
}
Kostenlos starten →